Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated With Interferon Beta 1a by 1h-NMR Spectroscopy
Neurotherapeutics - United States
doi 10.1007/s13311-019-00721-8
Full Text
Open PDFAbstract
Available in full text
Date
February 28, 2019
Authors
Publisher
Springer Science and Business Media LLC